Skip to content

13F-HR filed by New Leaf Venture Partners, L.L.C.

New Leaf Venture Partners, L.L.C. filed this 13F-HR for the quarter ended 2015-12-31, filed 2016-02-16, with 10 holding rows worth $149,381,000.

Accession
0001631614-16-000005
Filed
2016-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2015

A holdings report, 10 entries on the cover page, a total value of $149,381,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $149,381,000 with VALUE read as thousands by filing date, 13F file number 028-16681. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
EDGE THERAPEUTICS INC279870109COM2,344,868$29,311,000thousands by filing date
VERSARTIS INC92529L102COM2,039,223$25,266,000thousands by filing date
DIMENSION THERAPEUTICS INC25433V105COM2,059,283$23,229,000thousands by filing date
Alder Biopharmaceuticals Inc.14339105 Com500,398$16,528,000thousands by filing dateThe CUSIP as filed is malformed.
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS1,377,497$15,841,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW546,998$13,215,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock784,159$12,507,000thousands by filing date
DERMIRA INC24983L104COM177,022$6,127,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM704,572$5,383,000thousands by filing date
CHIMERIX INC COM16934W106Stock220,533$1,974,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001631614-16-000005this filing2016-02-16acceptance time not in the bulk data set